Frankfurt - Delayed Quote EUR
Ovid Therapeutics Inc. (1OT.F)
0.2260
+0.0300
+(15.31%)
As of 8:06:17 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 7 | 5 |
| Avg. Estimate | 25k | 42.5k | 210.86k | 300k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 50k | 150k | 566k | 600k |
| Year Ago Sales | 148k | 169k | 566k | 210.86k |
| Sales Growth (year/est) | -83.11% | -74.85% | -62.75% | 42.27% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1OT.F | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Upgrades & Downgrades
| Maintains | BTIG: Buy to Buy | 3/24/2025 |
| Maintains | Wedbush: Outperform to Outperform | 3/12/2025 |
| Upgrade | Oppenheimer: Perform to Outperform | 1/29/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/4/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/30/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/19/2024 |
Related Tickers
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
1VT.MU Viking Therapeutics Inc
22.46
+0.42%
EXOZ eXoZymes, Inc.
13.53
+14.76%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
RAPP Rapport Therapeutics, Inc.
11.38
-1.47%
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
BCAX Bicara Therapeutics Inc.
15.51
+12.23%
MBX MBX Biosciences, Inc.
8.99
+4.05%
SEPN Septerna, Inc.
6.14
+2.85%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%